IL6 and COVID-19: Most of the immune response pathways often reported for COVID-19 do not show changed activity including type 1 interferon signalling pathway (WP4868), TGF-beta signalling pathway (WP366), IL-1 signalling pathway (WP2332), IL-6 signalling pathway (WP364), Toll-like receptor signaling related to MyD88 (WP3858), TNF-related weak inducer of apoptosis (TWEAK) signaling pathway (WP2036), or p38 MAPK signaling pathway (WP400).